Focus Partners Advisor Solutions LLC Invests $212,000 in Encompass Health Corporation $EHC

Focus Partners Advisor Solutions LLC bought a new stake in shares of Encompass Health Corporation (NYSE:EHC) in the 2nd quarter, according to its most recent filing with the SEC. The institutional investor bought 1,733 shares of the company’s stock, valued at approximately $212,000.

Several other institutional investors and hedge funds also recently made changes to their positions in EHC. Cambridge Investment Research Advisors Inc. lifted its stake in shares of Encompass Health by 30.1% in the first quarter. Cambridge Investment Research Advisors Inc. now owns 9,597 shares of the company’s stock valued at $972,000 after buying an additional 2,218 shares during the period. Allspring Global Investments Holdings LLC increased its stake in Encompass Health by 51.4% during the first quarter. Allspring Global Investments Holdings LLC now owns 69,231 shares of the company’s stock valued at $7,012,000 after acquiring an additional 23,518 shares during the period. KBC Group NV raised its holdings in Encompass Health by 6.1% in the 1st quarter. KBC Group NV now owns 4,557 shares of the company’s stock valued at $462,000 after acquiring an additional 263 shares in the last quarter. Teacher Retirement System of Texas lifted its position in shares of Encompass Health by 32.7% in the 1st quarter. Teacher Retirement System of Texas now owns 61,305 shares of the company’s stock worth $6,209,000 after acquiring an additional 15,120 shares during the period. Finally, OneDigital Investment Advisors LLC acquired a new stake in shares of Encompass Health during the 1st quarter worth approximately $263,000. Institutional investors own 97.25% of the company’s stock.

Insider Activity

In other Encompass Health news, EVP Patrick William Tuer sold 1,020 shares of Encompass Health stock in a transaction on Wednesday, August 27th. The shares were sold at an average price of $123.59, for a total transaction of $126,061.80. Following the completion of the sale, the executive vice president owned 18,846 shares of the company’s stock, valued at approximately $2,329,177.14. The trade was a 5.13% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Company insiders own 2.00% of the company’s stock.

Encompass Health Stock Down 2.5%

Shares of NYSE:EHC opened at $113.86 on Friday. The company has a quick ratio of 1.06, a current ratio of 1.06 and a debt-to-equity ratio of 0.76. The firm has a market cap of $11.47 billion, a P/E ratio of 21.52, a P/E/G ratio of 2.20 and a beta of 0.93. Encompass Health Corporation has a 12 month low of $87.85 and a 12 month high of $127.99. The company’s 50-day moving average price is $124.22 and its two-hundred day moving average price is $118.99.

Encompass Health (NYSE:EHC) last announced its earnings results on Wednesday, March 16th. The company reported $0.93 earnings per share for the quarter. Encompass Health had a net margin of 9.33% and a return on equity of 18.19%. The company had revenue of $136.30 million during the quarter. Encompass Health has set its FY22 guidance at $3.83-$4.19 EPS. As a group, research analysts forecast that Encompass Health Corporation will post 4.8 EPS for the current fiscal year.

Encompass Health Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Thursday, January 15th. Investors of record on Friday, January 2nd will be issued a $0.19 dividend. The ex-dividend date is Friday, January 2nd. This represents a $0.76 annualized dividend and a yield of 0.7%. Encompass Health’s dividend payout ratio (DPR) is currently 14.37%.

Wall Street Analyst Weigh In

A number of research analysts recently commented on EHC shares. UBS Group upped their target price on Encompass Health from $140.00 to $150.00 and gave the company a “buy” rating in a research note on Thursday, October 2nd. Bank of America increased their price objective on shares of Encompass Health from $145.00 to $160.00 and gave the company a “buy” rating in a research note on Wednesday, September 10th. Weiss Ratings reaffirmed a “buy (b+)” rating on shares of Encompass Health in a report on Wednesday, October 8th. Zacks Research raised shares of Encompass Health from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, October 21st. Finally, KeyCorp increased their price target on shares of Encompass Health from $135.00 to $140.00 and gave the stock an “overweight” rating in a research report on Tuesday, September 16th. Two analysts have rated the stock with a Strong Buy rating and eight have given a Buy rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Buy” and a consensus price target of $142.86.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.